DGAP-News: MPH Mittelständische Pharma Holding AG:
(firmenpresse) - DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): Final
Results/Preliminary Results
MPH Mittelständische Pharma Holding AG:
08.03.2012 / 08:00
---------------------------------------------------------------------
MPH Mittelständische Pharma Holding AG:
Preliminary result year 2011
Compared to the previous year the turnover increased in year 2011 by +29.4%
and reached 145.51m Euro. The net profit was 8.65m Euro.
A net profit/share of 23 Cent was earned. The Management Board proposes a
dividend payment of 20 Cent/preference share.
The company MPH Mittelständische Pharma Holding AG today presents the
preliminary results for year 2011.
MPH group achieved a turnover to the amount of 145.51m Euro (prior year
112.41m Euro) and a net profit to the amount of 8.65m Euro (prior year
9.12m Euro).
In Germany the mandatory manufacturer discount related to patent-protected
non-reference price drugs was increased in August 2010 from 6 % to 16 %.
These legislatively prescribed price interventions apply for a limited
period of time up to the year 2013, and significantly degrade the result
situation of the pharmaceutical companies. In spite of the increase of the
mandatory manufacturer discount by 10%, valid for the full year 2011, the
net yield only decreased from 8.12% to 5.94% annual profit. The MPH group
is counteracting the regulatory challenges with an extension of the product
portfolio and through the development of new business markets.
For the current business year 2012 the MPH group is estimating a turnover
growth as in the previous year, and a net yield also as in the previous
year.
About the company MPH Mittelständische Pharma Holding AG:
The Berlin based company MPH Mittelständische Pharma Holding AG has
strategically concentrated its activities on growth segments in the
pharmaceutical market. With pharmaceutical products based on patent-free
and patent-protected active substances, which are made available through
the MPH group in the therapeutic areas oncology, HIV, rheumatology,
neurology and cardiovascular diseases, a contribution is made towards cost
reduction in the healthcare sector.
MPH Mittelständische Pharma Holding AG has been listed on the stock
exchange (Open Market) in Frankfurt as of September, 1, 2009. An
application for listing in the Entry Standard was filed.
Key capital market data for MPH Mittelständische Pharma Holding AG:
Subscribed Capital: EUR 38.050.000
Stock exchange listed class of shares: Owner held-preferred shares
Number of circulating preference shares: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock Exchange code: 93MV
End of Corporate News
---------------------------------------------------------------------
08.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
159748 08.03.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.03.2012 - 08:00 Uhr
Sprache: Deutsch
News-ID 122955
Anzahl Zeichen: 8724
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 272 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MPH Mittelständische Pharma Holding AG:"
steht unter der journalistisch-redaktionellen Verantwortung von
MPH Mittelständische Pharma Holding AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
